Journal article
Effects of Early Intervention With Inhaled Budesonide on Lung Function in Newly Diagnosed Asthma
Abstract
STUDY OBJECTIVES: Asthmatic patients lose lung function faster than normal subjects. The effectiveness of early intervention with inhaled corticosteroids on this decline in lung function is not established in recent-onset disease.
DESIGN: The Inhaled Steroid Treatment as Regular Therapy in Early Asthma study was a randomized, double-blind study in 7,165 patients (5 to 66 years old), with persistent asthma for < 2 years to determine whether early intervention with low-dose inhaled budesonide prevents severe asthma-related events and the decline in lung function. Patients received budesonide (200 mug qd for children < 11 years old and 400 mug qd for others) or placebo for 3 years in addition to usual asthma medications.
RESULTS: Treatment with budesonide significantly improved prebronchodilator and postbronchodilator FEV(1) percentage of predicted and reduced the mean declines from baseline for postbronchodilator FEV(1) at 1 year and 3 years: - 0.62% and - 1.79% for budesonide and - 2.11% and - 2.68% for placebo, respectively (p < 0.001). The decline was more marked for male patients, active smokers, and patients > 18 years old, and the smallest …>
Authors
O’Byrne PM; Pedersen S; Busse WW; Tan WC; Chen Y-Z; Ohlsson SV; Ullman A; Lamm CJ; Pauwels RA; Group OBOTSI
Journal
Chest, Vol. 129, No. 6, pp. 1478–1485
Publisher
Elsevier
Publication Date
6 2006
DOI
10.1378/chest.129.6.1478
ISSN
0012-3692